Pimavanserin: Potential Treatment For Dementia-Related Psychosis

Psychosis is common across dementia types with a prevalence of 20% to 70%. Currently, no pharmacologic treatment is approved for dementia-related psychosis. Atypical antipsychotics are frequently used to treat these disorders, despite significant safety concerns. Pimavanserin, a selective 5-HT2A inv...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Prev Alzheimers Dis
Hlavní autoři: Cummings, Jeffrey, Ballard, C., Tariot, P., Owen, R., Foff, E., Youakim, J., Norton, J., Stankovic, S.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2018
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6413822/
https://ncbi.nlm.nih.gov/pubmed/30298184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14283/jpad.2018.29
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky